Population
Transgenic mice with cardiac-specific overexpression of wild-type p90 ribosomal S6 kinase and a…
Comparison
Ischemia/reperfusion with or without ACE-I or… vs Non-Tg littermate controls; untreated mice.
Design
Preclinical
Authors
Loading...
Suggests p90RSK-dependent RAS benefit in diabetic I/R models; leaves open translation to human diabetic cardiomyopathy.
p90RSK plays a critical role in hyperglycemia-mediated myocardial PRECE induction, providing a potential molecular mechanism for RAS augmentation in diabetic hearts and a therapeutic target for diabetic cardiomyopathy.
Itoh et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: